Related Experiment Video

Updated: Dec 16, 2025

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

14.3K

Chagas Disease Infection Reactivation after Heart Transplant

Maria da Consolação Vieira Moreira1, José Renan Cunha-Melo2

  • 1School of Medicine, Federal University of Minas Gerais (UFMG), Av. Alfredo Balena 190, Belo Horizonte CEP 30130-110, MG, Brazil.

Tropical Medicine and Infectious Disease
|July 3, 2020
PubMed

Insights

Chagas disease reactivation poses risks for heart transplant recipients. Early recognition and treatment are crucial for managing this Trypanosoma cruzi infection post-transplant.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Transplantation Immunology

Background:

  • Chagas disease, caused by Trypanosoma cruzi, is a leading cause of heart failure in Latin America.
  • Globalization has led to increased migration of T. cruzi-infected individuals to non-endemic countries.
  • Heart transplantation (HTx) is a potential treatment for end-stage chagasic cardiomyopathy.

Purpose of the Study:

  • To review the complexities of Chagas disease reactivation in heart transplant recipients.
  • To highlight challenges in managing T. cruzi infection post-transplantation.
  • To emphasize the need for awareness among heart transplant professionals.

Main Methods:

  • Literature review on Chagas disease reactivation after HTx.
  • Analysis of diagnostic challenges in differentiating rejection from reactivation.
  • Discussion of management strategies for T. cruzi infection in transplant patients.

Main Results:

  • Immunosuppression post-HTx can trigger T. cruzi reactivation.
  • Reactivation increases morbidity and mortality in heart transplant recipients.
  • Distinguishing reactivation from rejection is clinically challenging.

Conclusions:

  • Awareness and early diagnosis of T. cruzi reactivation are vital in heart transplant recipients.
  • Effective management strategies are needed to improve outcomes.
  • Further research is required to optimize care for these patients.

Keywords:
Chagas disease reactivationcardiac allograft rejectionchagasic cardiomyopathyheart transplantationtreatment of reactivation

More Related Videos

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.5K
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.6K

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
108
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
301
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
204
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
784
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
139
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
223